FindTrial
Sign In

Effect of CYP3A4*1G Genetic Polymorphisms on the median effective dose of sulfentanyl in inhibiting postoperative pain following gynecological laparoscopic operation

The relationship between CYP3A4*1G Genetic Polymorphisms and Precision Medicine of sulfentanyl

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17012982
Enrollment
Unknown
Registered
2017-10-14
Start date
2017-10-13
Completion date
Unknown
Last updated
2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecological laparoscopic operation

Interventions

Case series:Nil

Sponsors

Department of Anesthesiology, Changzhou 2nd People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 30-60 years with American Society of Anesthesiologists (ASA) physical status I or II.

Exclusion criteria

Exclusion criteria: Any patients with hypertension or other cardiovascular disease, diabetic patients, patients who had kidney or liver disease, chronic pain patients, those taking pain drugs, or their weight is above 130 kg.

Design outcomes

Primary

MeasureTime frame
median effective dose;—

Secondary

MeasureTime frame
Pain threshold;—

Countries

China

Contacts

Public ContactWU Zhou-quan

Department of Anesthesiology, Changzhou 2nd People's Hospital

wuzhouquan2005@126.com+86 13861023270

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026